Bulent Mutus funded by Astra Zeneca...
Dr. Bulent Mutus has received a contract from AstraZeneca to explore the effects of a new antiplatelet drug on plasma membrane cholesterol raft-ADP receptor interactions.
Click here for more information on his research program.
Dr. Bulent Mutus has received a contract from AstraZeneca to explore the effects of a new antiplatelet drug on plasma membrane cholesterol raft-ADP receptor interactions.
Click here for more information on his research program.
